EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
Upcoming Industry Meetings and Webinars, September 1 - November 30, 2025
-
Here are the industry events and webinars I'm aware of for September 1 -
November 30, 2025. I don't have anything to do with any of these from a
plannin...
3 days ago
No comments:
Post a Comment